Tammi S.

Cleveland, OH

Tammi’s Testimonial for COPD Treatment at the Lung Institute

Age: 41 | Location: Cleveland, OH | Condition: COPD

When daily chores, walking and having a conversation left her out of breath, Tammi S. knew it was time to try something different for her chronic obstructive pulmonary disease (COPD). She contacted the Lung Institute to learn more about cellular therapy options. She spoke with Lung Institute staff several times before she decided to have treatment in August 2015.

Tammi and her family noticed improvements to her health quickly, and over time, Tammi’s daily activities increased. Now, Tammi can walk, have a conversation and polish her own nails without feeling short of breath. Interested in what her pulmonary function test (PFT) would report, Tammi went to her doctor. Skeptical he would see improvement, the doctor performed a PFT, finding that Tammi’s lung function went from 58% before treatment to 78% after treatment. Tammi looks forward to continued improvement and says she doesn’t have a cough, feels happy and loves life.

If you or a loved one has COPD, or another lung disease, and would like to see results like Tammi’s, contact us at 888-745-6697 to learn more.

Nancy H.
Bellingham, WA
David V.
Englewood, FL
Herbert K.
Keller, TX
Don C.
Lakewood, OH
Kathleen B.
Amherst, OH
Denise F.
Smiths Creek, MI
Judy Q.
French Village, MO
Penny K.
Omaha, NE
Ronnie G.
Warren, TX
Bill B.
Wellsboro, PA
Joseph O.
Selden, NY
Rhonda S.
Macomb, MI
Tammi S.
Cleveland, OH
Becky D.
Schererville, IN
Rickie S.
Elizabeth City, NC
Brad E.
Nashville, TN
Paul B.
Chagrin Falls, OH
Lois S.
Sun City, AZ
Karl T.
Hampstead, NC
June B.
Madeira Beach, FL
Jim D.
Boca Raton, FL
Marvin S.
Lakeland, FL
Vickie B.
San Antonio, TX
Audrey S.
Fairbanks, AK
Linus S.
Hays, KS

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.